Polymer nanocomposite particles of S-nitrosoglutathione: A suitable formulation for protection and sustained oral delivery. En savoir plus sur Polymer nanocomposite particles of S-nitrosoglutathione: A suitable formulation for protection and sustained oral delivery.
[Hydrogen sulfide: A promising therapy in neuroprotection following cardiac arrest?]. En savoir plus sur [Hydrogen sulfide: A promising therapy in neuroprotection following cardiac arrest?].
Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells. En savoir plus sur Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells.
Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study. En savoir plus sur Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study.
Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid. En savoir plus sur Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid.
Nanoparticles as tools for evaluation of cellular redox state. En savoir plus sur Nanoparticles as tools for evaluation of cellular redox state.
Encapsulation of low molecular weight heparins: influence on the anti-Xa/anti-IIa ratio. En savoir plus sur Encapsulation of low molecular weight heparins: influence on the anti-Xa/anti-IIa ratio.
Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification. En savoir plus sur Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification.
Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement. En savoir plus sur Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement.
Indirect evidence for a Fc gamma receptor on guinea pig platelets: guinea pig represents a promising species for the investigation of human disorders with immune platelet activation. En savoir plus sur Indirect evidence for a Fc gamma receptor on guinea pig platelets: guinea pig represents a promising species for the investigation of human disorders with immune platelet activation.
